Shuimu BioSciences, a Chinese start-up specialising in advanced imaging devices for viruses and smaller biomolecules, is aiming for an initial public offering in 2027 after selling its first self-developed product this year, according to CEO Allen Guo Chunlong. The company focuses on cryo-electron microscopy (Cryo-EM), a technique that involves firing beams of electrons at flash-frozen…
By Andrew Silver SHANGHAI (Reuters) -Pharmaceutical research and development firms in China are increasingly interested in procuring critical supplies known as reagents from local manufacturers, industry executives and managers said, as they seek to cut costs and delivery times. Western reagent suppliers including U.S.-based Thermo Fisher Scientific and Germany’s Merck have profited in the world’s…
This might be the most critical week for investors in years. In fact, in over two decades of investing, and more than a decade as a professional analyst, I’ve never seen a single week with this many potentially market-moving headlines. Between earnings surprises, critical inflation and jobs data, a Federal Reserve decision, and a looming…